TL/DR –
The U.S. electro-medical and electrotherapeutic apparatus market is forecasted to reach $37.91 billion by 2030, growing at a CAGR of 6.4%, driven by the increasing prevalence of chronic disorders, technological advancements, the growing preference for minimally invasive treatment options and the rising geriatric population. Growth is particularly driven by the rising prevalence of diseases such as diabetes, cardiovascular conditions, respiratory disorders, and neurological diseases such as Alzheimer’s and Parkinson’s. Technological advancements, including the integration of AI, wearable devices and continuous monitoring systems into medical equipment, are significantly boosting the market growth.
U.S. Electro-medical And Electrotherapeutic Apparatus Market Growth & Trends
The U.S. electro-medical and electrotherapeutic apparatus market is projected to reach USD 37.91 billion by 2030, growing at a CAGR of 6.4%. Boosting factors include rising chronic disorders, technology advancements, preference for minimally invasive treatments, and an increasing elderly population. Data from the Population Reference Bureau shows Americans aged 65 and older will increase by 47%, from 58 million in 2022 to 82 million by 2050.
Increasing chronic diseases like diabetes, cardiovascular conditions, respiratory disorders, and neurological diseases like Alzheimer’s and Parkinson’s create a growing need for advanced diagnostic, therapeutic, and monitoring solutions. The American Diabetes Association reports that in 2021, 38.4 million Americans, or 11.6% of the population, were living with diabetes. This rising demand leads to the growth of the electro-medical and electrotherapeutic devices market.
Technological advancements contribute to the growth of the U.S. electro-medical and electrotherapeutic apparatus market. Companies are innovating and introducing new products, integrating advanced technologies like artificial intelligence, wearable devices, and continuous monitoring systems. In June 2024, Abbott obtained FDA clearance for two new over-the-counter continuous glucose monitoring (CGM) systems – Lingo and Libre Rio, based on Abbott’s FreeStyle Libre CGM technology.
U.S. Electro-medical And Electrotherapeutic Apparatus Market Highlights
- Diagnostic equipment segment led the product segment with a 38.2% share in 2024.
- The therapeutic equipment segment is set to grow at the fastest CAGR.
- The cardiology segment held the largest market share of 28.3% in 2024.
- Neurology segment will grow at the fastest rate.
- Hospitals held a 45.8% market share in 2024.
- Diagnostic centers segment will grow at the fastest rate.
U.S. Electro-medical And Electrotherapeutic Apparatus Market Segmentation
Grand View Research segmented the U.S. electro-medical and electrotherapeutic apparatus market into product, application, and end-use outlooks:
U.S. Electro-medical And Electrotherapeutic Apparatus Product Outlook (Revenue, USD Million, 2018 – 2030)
U.S. Electro-medical And Electrotherapeutic Apparatus Application Outlook (Revenue, USD Million, 2018 – 2030)
- Cardiology
- Neurology
- Oncology
- Orthopedics
- Gynecology
- Urology
- Others
U.S. Electro-medical And Electrotherapeutic Apparatus End-use Outlook (Revenue, USD Million, 2018 – 2030)
List of Key Players in the U.S. Electro-medical And Electrotherapeutic Apparatus Market
—
Read More Health & Wellness News ; US News